Physician training in Russia helps advance treatment of cardiovascular disease.
At 70, Boris is doing his best to stay healthy. Having dealt with chest pains for years, the Moscow native says it’s challenging to get the healthcare he needs—from limited access to specialists to long wait times for test results. So, he’s doing his best to manage things on his own.
Boris’ story is all too familiar in Russia—a place where heart disease is the leading cause of death, with a 60 percent mortality rate. That statistic is not only scary, but costly. Chronic disease takes its toll on the local economy, keeping people out of work and more dependent on the healthcare system for support.
Professor Alexander Osiev is the leading cardiologist at Moniki Hospital in Moscow—one of the largest medical centers in Russia. He says a lack of stenting therapy expertise is a big part of Russia’s challenge in treating heart disease. “Stenting therapy is the easiest way to treat acute coronary syndromes,” he says. Today, among those diagnosed with heart disease, only seven percent receive stenting therapies.
Osiev feels one of the best ways to make a difference is to train more doctors on the latest technologies and therapies available. Vice President for Medtronic in Russia, Elena Plyasunova, along with Training and Education Manager for Medtronic Russia, Andrey Maltsev, agrees. “You really need to continue to explain to physicians what new therapies are evolving, what products may come to the market, how they can make it available to the patients, and how this will decrease the burden on the healthcare system,” explains Plyasunova.
Last year alone, Medtronic partnered with hospitals in Russia to train more than 5,000 physicians on the latest stenting technology. Osiev believes in the company’s education programs so much, he’s now a trainer himself and considers the partnership a win-win. “When you teach someone, you learn too,” he explains.
For Medtronic and our partners in Russia, we believe that shared knowledge can help transform the future of healthcare – and the future of patients like Boris.